| Ytd | 67.90% | |
| 1y | 89.66% |
| Open | 49.20 | Prev Close | 49.16 | Low | 49.00 | High | 50.35 | Mkt Cap | 7.66B |
| Vol | 569.87K | Avg Vol | 2.38M | EPS | 2.76 | P/E | 18.13 | Forward P/E | 16.78 |
| Beta | 1.62 | Short Ratio | 10.83 | Inst. Own | 69.96% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-03 | 50-d Avg | 51.08 | 200-d Avg | 37.10 | 1yr Est | 77.83 |
TG Therapeutics, Inc. (NASDAQ: TGTX - Get Free Report) has earned an average rating of "Hold" from t
Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage gene editing company utilizing its nove
Empowered Funds LLC lifted its position in TG Therapeutics, Inc. (NASDAQ: TGTX) by 49.9% in the unde
TG Therapeutics, Inc. remains a Buy as BRIUMVI's momentum supports a durable, growing multiple scler
TG Therapeutics misses Q2 earnings estimates, but surging Briumvi demand lifts revenues y/y and prom
TG Therapeutics, Inc. (TGTX) Q2 2026 Earnings Call Transcript
The headline numbers for TG Therapeutics (TGTX) give insight into how the company performed in the q
TG Therapeutics NASDAQ: TGTX reported second-quarter 2026 revenue of $240 million and raised its ful
TG Therapeutics (TGTX) came out with quarterly earnings of $0.05 per share, missing the Zacks Consen
Second quarter 2026 total global revenue of approximately $240 million, including BRIUMVI U.S. net p
NEW YORK, July 29, 2026 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX), today announced th
TG Therapeutics (TGTX) possesses the right combination of the two key ingredients for a likely earni
NEW YORK, July 21, 2026 /PRNewswire/ -- Kuehn Law, PLLC, a shareholder litigation law firm, is inves
NEW YORK, July 16, 2026 (GLOBE NEWSWIRE) -- Kuehn Law, PLLC, a shareholder litigation law firm, is i
HC Wainwright & Co. analyst Emily Bodnar maintains TG Therapeutics (NASDAQ:TGTX) with a Buy a
Incyte and TG Therapeutics are seeing strong share growth, backed up by booming revenue and earnings
TGTX initiates a phase II study evaluating Briumvi in adult patients with treatment-resistant schizo
Phase 2 trial to evaluate the effects of B-cell depletion with BRIUMVI in approximately 60 patients
TG Therapeutics continues to witness rising Briumvi demand. Investors are closely watching the sales
This whale alert can help traders discover the next big trading opportunities. Whales are entities w
TG Therapeutics Inc. (NASDAQ:TGTX) shares are trading higher on Thursday as traders keep leaning int
3 health care stocks flashing warning: CAH RSI 77.7, TGTX RSI 79.8, AMRX RSI 76.9; all overbought, b
US stocks down, Dow Jones fell 150 pts on Wed. Caseys General Stores Inc (CASY) shares up 14.4% afte
Dow falls 296 points. Navitas Semi rises on partnership with Nvidia. Other gainers: ABVX, MMED, KELY
TCOM: -11% | Trip.com Group shares are trading lower after the company announce it is under investig
Retail investors are preparing for another busy week of earnings season with more than 1,600 compani
Companies Reporting Before The Bell • ICL Group (NYSE:ICL) is likely to report quarterly earnings a
Gainers
U.S. stocks traded higher, with the Dow Jones falling more than 30 points on Wednesday. Here are som
Companies Reporting Before The Bell • GSK (NYSE:GSK) is expected to report quarterly earnings at $1
Companies Reporting Before The Bell • Toyota Motor (NYSE:TM) is estimated to report earnings for it
Gainers
Companies Reporting Before The Bell • TG Therapeutics (NASDAQ:TGTX) is estimated to report quarterl
Companies Reporting Before The Bell • Gaotu Techedu (NYSE:GOTU) is expected to report earnings for
Gainers Allarity Therapeutics, Inc. (NASDAQ: ALLR) gained 240% to $0.90. Allarity Therapeutics, l
Gainers
Gainers Fast Radius, Inc. (NASDAQ: FSRD) shares climbed 172% to $0.2769 after dipping 40% on Wedn
Companies Reporting Before The Bell • IDEX Biometrics (NASDAQ:IDBA) is estimated to report earnings
Gainers Bonso Electronics International Inc. (NASDAQ: BNSO) shares jumped 132% to $11.12 after ju
On Wednesday, 73 stocks hit new 52-week lows.